There have been no adverse gatherings or changes from baseline in serologic scientific studies and critical signs in almost any of your participants. The procedure's agony-relieving results were being confirmed via frequent, 12-7 days stick to-ups, confirming the security and effectiveness of BTX-A on Continual ON and suggesting that this technique